S100β and Neuron Specific Enolase Levels in Liver Transplantation

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

June 20, 2017

Primary Completion Date

March 1, 2021

Study Completion Date

May 20, 2021

Conditions
Liver Transplantation
Interventions
DIAGNOSTIC_TEST

S100β and Neuron specific enolase (NSE)

S100β is 10.4 kDa protein. Synthesized with end feet processes of astrocytes in the brain S100β belongs to low molecular weight EF-hand type acidic calcium binding protein superfamily. This protein is metabolized in the kidneys and removed with urine. It is shown that S100β does not show differences due to ethnical groups or genders and is not affected by circadian rhythm. Although S100β is also found in other tissues, it is in higher concentrations in the brain so it can be used as an early indicator for brain damage.NSE is an SSS protein which exists in neurons and neuroendocrine tissues. NSE plays a role in glycolytic route in neurons as intracytoplasmic enzyme increasing serum level in case of neuron damage. Whilst S100β is the marker of astroglia dysfunction, NSE is the marker of neuronal dysfunction.

Trial Locations (1)

07059

Akdeniz University Medical Faculty Department of Anesthesiology and Reanimation, Antalya

All Listed Sponsors
lead

Bora Dinc

OTHER

NCT03453047 - S100β and Neuron Specific Enolase Levels in Liver Transplantation | Biotech Hunter | Biotech Hunter